<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Eyeing India&#8217;s Pharma Industry</title>
	<atom:link href="http://blog.pharmtech.com/2011/03/09/eyeing-indias-pharma-industry/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmtech.com/2011/03/09/eyeing-indias-pharma-industry/</link>
	<description>The blog of Pharmaceutical Technology magazine</description>
	<lastBuildDate>Thu, 09 May 2013 23:30:55 -0400</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Dr,LRamaswamy</title>
		<link>http://blog.pharmtech.com/2011/03/09/eyeing-indias-pharma-industry/comment-page-1/#comment-36356</link>
		<dc:creator>Dr,LRamaswamy</dc:creator>
		<pubDate>Mon, 11 Apr 2011 19:11:28 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=3930#comment-36356</guid>
		<description>Health Care and Education are clearly the two key Industry where India will grow fast in this decade and give a tough competion to the other developed markets.  Also we will witness a few more buyouts of indian pharma companies by multinational giants in the next 5 years.  This will attract new investment in the area of Research &amp; Development from developed countries to this part of the continent.</description>
		<content:encoded><![CDATA[<p>Health Care and Education are clearly the two key Industry where India will grow fast in this decade and give a tough competion to the other developed markets.  Also we will witness a few more buyouts of indian pharma companies by multinational giants in the next 5 years.  This will attract new investment in the area of Research &amp; Development from developed countries to this part of the continent.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dr. James J. Gillespie</title>
		<link>http://blog.pharmtech.com/2011/03/09/eyeing-indias-pharma-industry/comment-page-1/#comment-35812</link>
		<dc:creator>Dr. James J. Gillespie</dc:creator>
		<pubDate>Tue, 15 Mar 2011 04:56:54 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=3930#comment-35812</guid>
		<description>Just as the Indian Government is thinking of 2011-2020 as the &quot;Decade of India&quot; more broadly.  With regard to the pharmaceutical industry specifically, there is reason to think it will be India&#039;s Decade on the production and consumption side.  The US will likely remain the key stage-gate (and Japan &amp; Europe will remain essential), but India will be increasingly important.</description>
		<content:encoded><![CDATA[<p>Just as the Indian Government is thinking of 2011-2020 as the &#8220;Decade of India&#8221; more broadly.  With regard to the pharmaceutical industry specifically, there is reason to think it will be India&#8217;s Decade on the production and consumption side.  The US will likely remain the key stage-gate (and Japan &amp; Europe will remain essential), but India will be increasingly important.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: albifrancis</title>
		<link>http://blog.pharmtech.com/2011/03/09/eyeing-indias-pharma-industry/comment-page-1/#comment-35652</link>
		<dc:creator>albifrancis</dc:creator>
		<pubDate>Thu, 10 Mar 2011 07:40:50 +0000</pubDate>
		<guid isPermaLink="false">http://blog.pharmtech.com/?p=3930#comment-35652</guid>
		<description>2012 is going to be a great year for indian generic makeres as brands like lipitor going to loose its patient protection at the end of this year</description>
		<content:encoded><![CDATA[<p>2012 is going to be a great year for indian generic makeres as brands like lipitor going to loose its patient protection at the end of this year</p>
]]></content:encoded>
	</item>
</channel>
</rss>
